Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Beth Hecht currently holds 1,193,173 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Beth Hecht has been a net seller of XERS stock. They have purchased $49.5K and sold $567.6K worth of shares.
Beth Hecht's most recent insider trade was on May 1, 2026, when they sold 16,667 shares at $6.23 per share.
Beth Hecht serves as Executive at Xeris Biopharma Holdings, Inc. (XERS). They have executed 34 insider transactions totaling $617.1K over their tenure at the company.
Beth Hecht holds the position of Executive at Xeris Biopharma Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Beth Hecht has shown a selling trading pattern, with $49.5K in total purchases and $567.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Beth Hecht was on Jan 2, 2026, when they sold $123.8K worth of XERS shares. This transaction involved 16,667 shares at $7.43 per share.
Beth Hecht currently owns 1,193,173 shares of Xeris Biopharma Holdings, Inc. (XERS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Beth Hecht's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Beth Hecht has 34 Form 4 filings on record as an insider at Xeris Biopharma Holdings, Inc..
Set alerts for Beth Hecht and 40,000+ other insiders.